Rho/Rho激酶信号转导通路与心力衰竭的研究进展
被引量:1
摘要
Rho/Rho激酶信号通路的关键信号分子包括Rho蛋白、Rho激酶和肌球蛋白磷酸酶。Rho蛋白是Ras超家族中小分子G蛋白的成员之一,具有GTP酶活性。Rho.GTP在细胞的信号转导通路中作为信号转换器或分子开关,与Rho激酶的Rho蛋白结合域结合,
出处
《广州医学院学报》
2010年第2期102-104,共3页
Academic Journal of Guangzhou Medical College
参考文献14
-
1Burridge K,Wennerberg K. Rho and Rac take center stage [J]. J Cell,2004,116(2) : 167-179.
-
2Etienne-Manneville S, Hall A. Rho GTPases in cell biology [J]. Nature,2002,420(12) : 629-635.
-
3Amano M, ho M, Kimura K, et al. Phosphorylation and activation of myosin by Rho-associated kinase (Rhokinase) [J]. J Biol Chem,1996,271 (34) :20246-20249.
-
4Koyama M, Ito M, Feng J,et al. Phosphorylation of CPI-17, an inhibitory phosphoprotein of smooth muscle myosinphos phatase, by Rho kinase [ J ]. FEBSLett, 2000,475 ( 2 ) : 197- 200.
-
5Kitazawa T, Eto M, Woodsome TP, et al. Phosphorylation of the myosinphosphatase targeting subunit and CPI-17 during Ca2+ sensitization in rabbit smooth muscle [ J ]. J Physiol, 2003,546 ( 3 ) : 879-889.
-
6Indolfi C, Di Lorenzo E, Perrino C, et al. Hydroxymethylglutaryl coenzyme a reductase inhibitor simvastatin prevents cardiac hypertrophy induced by pressure overload and inhibits p21 ras activation, Circulation [ J ], 2002, 106 (16) :2118-2124.
-
7Morissette MR, Sah VP, Glembotski CC, et al. The Rho effector, PKN, regulates ANF gene transcription in cardiomyocytes through a serum response element [ J ]. Am J Physiol Heart Circ Physiol,2000,278(6) : 1769-1774.
-
8Satoh S, Ueda Y, Koyanagi M, et al. Chronic inhibition of Rho kinase blunts the process of left ventricular hypertrophy leading to cardiac contractile dysfunction in hypertension- induced heart failure [ J ]. J Mol Cell Cardiol, 2003,35 ( 1 ) :59-70.
-
9Kaibuchi K, Kuroda S, Amano M. Regulation of the cytoskeleton and cell adhesion by the Rho family GTPases in mammalian cells [ J ]. Annu Hey Siochem, 1999,68 (2) : 459-486.
-
10Suematsu N, Satoh S, Kinugawa S, et al. Alphal- adrenoceptor-Gq-RhoA signaling is upregulated to increase myofibrillar Ca2+ sensitivity in failing hearts [J]. Am J Physiol Heart Circ Physiol,2001,281 (2) : 637-646.
二级参考文献33
-
1罗洁,闵苏.新型脑、心血管活性药——法舒地尔[J].中国新药与临床杂志,2006,25(12):941-945. 被引量:47
-
2Lips D J, deWindt LJ, van Kraaij D J, et al. Molecular determinants of myocardial hypertrophy and failure: alternative pathways for beneficial and maladaptive hypertrophy [J]. Eur Heart J, 2003 ; 24 ( 10 ) : 883-96.
-
3Loirand G, Guerin P, Pacaud P. Rho kinases in cardiovascular physiology and pathophysiology[J]. Circ Res,2006 ;98 (3) :322-34.
-
4Hattori T, Shimokawa H, Higashi M, et al. Long-term inhibition of Rho-kinase suppresses left ventrieular remodeling after myocardial infarction in mice[J]. Circulation,2004 ; 109 ( 18 ) :2234-9.
-
5Mukai Y, Shimokawa H, Matoba T, et al. Involvement of Rho-kinase in hypertensive vascular disease : a novel therapeutic target in hypertension [J]. FASEB J,2001 ;15 (6) :1062-4.
-
6Phrommintikul A,Tran L, Kompa A, et al. Effects of a rho kinase inhibitor on pressure overload induced cardiac hypertrophy and associated diastolic dysfunction[J]. Am J Physiol Heart Circ Physiol,2008 ;294 (4) :H1804- 14.
-
7Higashi M, Shimokawa H, Hattori T, et al. Long-term inhibition of Rho-kinase suppresses angiotensin Ⅱ-induced cardiovascular hypertrophy in rats in vivo: effect on endothelial NAD (P)H oxidase system [J]. Circ Res, 2003 ;93 (8) :767-75.
-
8Yamazaki T, Komuro I, Zou Y ,et al. Norepinephrine induces the raf-1 kinase/mitogen-activated protein kinase cascade through both α1 and β-adrenoceptors [J]. Circulation, 1997 ; 95 ( 5 ) : 1260 -8.
-
9Ocaranza MP, Diaz-Araya G, Chiong M, et al. Isoproterenol and angiotensin Ⅰ-converting enzyme in lung,left ventricle,and plasma during myocardial hypertrophy and fibrosis[J]. J Cardiovasc Pharmacol,2002 ;40 (2) : 246-54.
-
10Takemoto Y, Yoshiyama M, Takeuchi K, et al. Increased JNK, AP-1 and NF-kappa B DNA binding activities in isoproterenol-induced cardiac remodeling[J]. J Mol Cell Cardiol,1999 ;31 (11) :2017-30.
共引文献4
-
1郝春华,王维亭,赵专友,汤立达.法舒地尔对心脑血管疾病的药理作用及临床应用[J].现代药物与临床,2010,25(6):411-416. 被引量:26
-
2武星,李虹伟,李卫萍.Rho激酶与心血管疾病[J].中国心血管杂志,2011,16(5):393-395. 被引量:9
-
3魏易洪,吴申,曹敏,周莉,周端.参蛤散对压力负荷性心衰大鼠血流动力学及RhoA、ROCK1的作用[J].中西医结合心脑血管病杂志,2014,12(1):65-67. 被引量:11
-
4李广浩,曹敏,周端,唐靖一,邓兵.Rho/ROCK信号通路在慢性充血性心力衰竭中的作用[J].山东医药,2013,53(41):94-96. 被引量:1
同被引文献14
-
1李娜,孔一慧,李为民.Rho激酶抑制剂与心力衰竭关系的研究进展[J].心血管病学进展,2009,30(4):673-676. 被引量:7
-
2急性心力衰竭诊断和治疗指南[J].中华心血管病杂志,2010,38(3):195-208. 被引量:836
-
3代铁成,赵月.不同剂量利尿剂联合应用对心衰患者血钾的影响[J].心血管康复医学杂志,2010,19(6):636-638. 被引量:6
-
4刘铭雅,魏盟.心肌梗死后心力衰竭发生机制及诊治进展[J].内科理论与实践,2014,9(1):21-25. 被引量:29
-
5陈华,吕妍琨,杜荣品.Rho激酶抑制剂与芪苈强心胶囊对慢性心力衰竭患者细胞因子的影响[J].世界中医药,2014,9(6):808-809. 被引量:9
-
6宋菲,张冬颖,刘剑.利尿剂在心力衰竭中的治疗进展[J].医学综述,2015,21(8):1427-1429. 被引量:17
-
7殷宇刚,严斌,吕磊.盐酸法舒地尔对老年冠心病心力衰竭的临床疗效[J].实用医学杂志,2015,31(14):2376-2378. 被引量:14
-
8姚玉龙,许开亮,叶明荣,雷鸣.肺部超声在指导急性左心衰竭患者呋塞米使用中的价值[J].蚌埠医学院学报,2016,41(2):161-163. 被引量:5
-
9刘峰,李哲,回志.慢性肾功能衰竭合并急性左心衰竭患者心肌酶、肌钙蛋白的临床意义[J].中国医药导刊,2016,18(5):450-451. 被引量:8
-
10王伟,边瓯,马宁,乔锐,丁亮.小剂量托伐普坦联合呋塞米治疗急性心力衰竭合并利尿剂抵抗超高龄老年患者临床评价[J].临床军医杂志,2016,44(6):601-604. 被引量:34
二级引证文献28
-
1伏继伟.奈西立肽与呋塞米治疗急性心力衰竭的效果及对肿瘤坏死因子样弱凋亡诱导物水平和用药安全的影响[J].中国误诊学杂志,2020(1):1-4.
-
2刘艳梅,李红旗,庞可心.沙库巴曲缬沙坦联合螺内酯治疗慢性心力衰竭对左室射血分数及血浆NT-proBNP的影响[J].湖南师范大学学报(医学版),2021,18(4):44-47. 被引量:30
-
3张德玉.大剂量呋塞米联合螺内酯治疗重度心力衰竭临床效果分析[J].中外医疗,2020,39(12):81-83.
-
4高硕.大剂量呋塞米持续静脉泵入在重度心衰患者临床治疗中的应用效果观察[J].临床研究,2020,28(8):73-75. 被引量:1
-
5康鹏喜,党敏.长托宁联合血液灌流对有机磷农药中毒患者心肌酶谱的影响及安全性分析[J].现代医学与健康研究电子杂志,2020,4(19):45-46. 被引量:1
-
6余登河.托拉塞米对急性心力衰竭患者心衰症状控制率及容量控制指标的影响[J].药品评价,2020,17(20):41-43. 被引量:2
-
7张生红,朱芳一,祝存奎.Rho激酶抑制剂对急性左心衰治疗中的临床应用价值[J].河北医学,2021,27(4):693-697. 被引量:4
-
8王宁,刘翠霞,曹罗文.益心舒胶囊联合螺内酯治疗对心力衰竭患者心功能及运动耐量的影响[J].四川解剖学杂志,2021,29(1):140-141. 被引量:2
-
9吴娅妮,韦晓洁,高雨桐,陈铭,韦秀莎,黄仁彬,张士军.杨桃根中2-十二烷基-6-甲氧基-2,5-二烯-1,4-环己二酮对糖尿病小鼠心肌损伤的影响[J].广西医科大学学报,2021,38(4):721-725. 被引量:1
-
10魏伟,黄爱荣.多巴胺联合卡托普利治疗小儿肺炎合并心力衰竭疗效观察[J].儿科药学杂志,2021,27(8):25-28. 被引量:7
-
1俞龙,解卫平.Rho激酶与呼吸系统疾病[J].国际呼吸杂志,2013,33(3):232-234. 被引量:1
-
2李瑞雪,胡艳丽,井丽巍.Rho/Rho激酶信号通路与缺氧性肺动脉高压[J].黑龙江医药,2015,28(3):470-472. 被引量:2
-
3王志,曹秉振.Rho/Rho激酶信号通路与缺血性脑血管病[J].国际脑血管病杂志,2008,16(5):375-379. 被引量:10
-
4尚可,袁展群,刘勇.Rho蛋白与动脉粥样硬化[J].国际心血管病杂志,2006,33(2):94-97. 被引量:1
-
5马小欣,赵慧颖,徐宝华.Rho/Rho激酶与动脉粥样硬化及冠心病的关系[J].中国微循环,2007,11(2):138-141. 被引量:9
-
6邢西迁,甘烨,吴尚洁.Rho/Rho激酶信号通路与肺部疾病[J].国际病理科学与临床杂志,2007,27(1):85-88. 被引量:5
-
7张子新,慕翠翠,吉虓,余陆娇.通心络对糖尿病动脉粥样硬化大鼠Rho/Rho激酶底物影响的研究[J].现代医学,2014,42(8):843-846. 被引量:5
-
8蔡茜,吴尚洁.COPD相关性肺动脉高压与Rho/Rho激酶信号通路[J].中国医疗前沿,2010,5(23):13-14. 被引量:4
-
9张佛生,张在兴.Rho/Rho激酶信号通路与胰腺疾病[J].国际外科学杂志,2012,39(8):550-552. 被引量:1
-
10Rho/Rho激酶及其抑制剂的临床应用[J].中华高血压杂志,2008,16(8):755-757. 被引量:1